Compare DexCom, Inc. (DXCM) vs Rockwell Automation (ROK) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
DexCom, Inc. vs Rockwell Automation — how do they compare? DexCom, Inc. trades at $89.2 (market cap $33.79B), while Rockwell Automation trades at $448.98 (market cap $49.64B). The key difference: Rockwell Automation is the larger of the two by market cap, and Rockwell Automation pays a 1.23% dividend while DexCom, Inc. pays none. Which is the better fit depends on your goals.
| DXCM | ROK | |
|---|---|---|
Market Cap | $33.79B | $49.64B |
Sector | Health | Industrials |
52-Week High | $89.53 | $495.08 |
52-Week Low | $54.84 | $333.75 |
Enterprise Value | $33.24B | $52.77B |
Dividend Yield | — | 1.23% |
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About DexCom, Inc.
Dexcom designs and commercializes continuous glucose monitoring systems for diabetics. CGM systems serve as an alternative to the traditional blood glucose meter process, and the company is evolving its CGM systems to include the disposable sensor and the durable receiver.
Read more on DXCM →About Rockwell Automation
Rockwell Automation is a pure-play automation competitor that is the successor entity to Rockwell International, which spun off its former Rockwell Collins avionics segment in 2001. As of fiscal 2021, the firm operates through three segments--intelligent devices, software and control, and lifecycle services. Intelligent devices contains its drives, sensors, and industrial components, software and control contains its information and network and security software, while lifecycle services contains its consulting and maintenance services as well as its Sensia JV with Schlumberger.
Read more on ROK →
